* CVRx Inc CVRX.OQ reported a quarterly adjusted loss of
$1.04
per share for the quarter ended in March, lower than the same
quarter last year, when the company reported EPS of -55 cents.
The mean expectation of six analysts for the quarter was for a
loss of 54 cents per share. Wall Street expected results to
range from -60 cents to -49 cents per share.
* Revenue rose 35% to $10.77 million from a year ago;
analysts
expected $11.41 million.
* CVRx Inc's reported EPS for the quarter was a loss of
$1.04.
* The company reported a quarterly loss of $22.15 million.
* CVRx Inc shares had fallen by 16.1% this quarter and
lost 51.4%
so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for CVRx Inc is
$32.50
This summary was machine generated from LSEG data April 30 at
10:54 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.54 -1.04 Missed
Dec. 31 2023 -0.54 -0.44 Beat
Sep. 30 2023 -0.58 -0.43 Beat
Jun. 30 2023 -0.58 -0.56 Beat